New Rule Requires Preauthorization of All Compounds, Regardless of Price

To clear up a “misunderstanding” among stakeholders, the Florida Division of Workers’ Compensation has clarified that all compounded drugs, regardless of cost, are now subject to preauthorization. WorkCompCentral reported June 30 that only compounds that exceeded a cost of $1,000 would require prior review, a statement that the DWC did not dispute when emailed questions. Since then, however, the agency has notified stakeholders that its interpretation of a state law allows for all compounds to face preauthorization regardless of the amount of the bill. The agency put ...